Article Navigation

Back To Main Page


 

More Articles

Just How Dangerous is Asbestos?


by: Mike Andrews

With the increase in the number of lung cancer cases in recent years, it is vitally important to educate ourselves on the risks and consequences of asbestos exposure which accounts for over 80% of all mesothelioma cancer cases; a form of cancer, caused by asbestos exposure, that can affect the lungs (Pleural form), abdomen (Peritoneal form), and even the membrane around the heart.. A hefty 2000 new cases are being diagnosed every year according to the National Cancer Institute, and that number is on the rise. This leaves the question to be asked...

Just how dangerous is asbestos exposure?

Significant exposure to any type of asbestos will increase the risk of lung cancer, mesothelioma and nonmalignant lung and pleural disorders, including asbestosis, pleural plaques, pleural thickening, and pleural effusions. This is based on observations of these diseases in groups of workers with cumulative exposures ranging from about 5 to 1,200 fiber-year/mL. The conclusion is supported by results from animal and mechanistic studies.

Tobacco smokers who have been exposed to asbestos have a "far greater-than-additive" risk for lung cancer than do nonsmokers who have been exposed, meaning the risk is greater than the individual risks from asbestos and smoking added together. The time between diagnosis of mesothelioma and the time of initial occupational exposure to asbestos commonly has been 30 years or more.

Asbestos Facts:

1. When asbestos fibers are inhaled, most fibers are expelled, but some can become lodged in the lungs and remain there throughout life. Fibers can accumulate and cause scarring and inflammation. Enough scarring and inflammation can affect breathing, leading to disease.

2. People are more likely to experience asbestos-related disorders when they are exposed to high concentrations of asbestos, are exposed for longer periods of time, and/or are exposed more often.

3. Inhaling longer, more durable asbestos fibers (such as tremolite and other amphiboles) contributes to the severity of asbestos-related disorders.

4. Exposure to asbestos, including tremolite, can increase the likelihood of lung cancer, mesothelioma, and non-malignant lung conditions such as asbestosis (restricted use of the lungs due to retained asbestos fibers) and changes in the lung lining.

5. Changes in the lining of the lungs (pleura) such as thickening, plaques, calcification, and fluid around the lungs (pleural effusion) may be early signs of asbestos exposure. These changes can affect breathing more than previously thought. Pleural effusion can be an early warning sign for mesothelioma (cancer of the lining of the lungs).

6. Most cases of asbestosis or lung cancer in workers occurred 15 years or more after the person was first exposed to asbestos.

7. Most cases of mesothelioma are diagnosed 30 years or more after the first exposure to asbestos.

8. Mesothelioma has been diagnosed in asbestos workers, family members, and residents who live close to asbestos mines.

9. Health effects from asbestos exposure may continue to progress even after exposure is stopped.

10. Smoking or cigarette smoke, together with exposure to asbestos, greatly increases the likelihood of lung cancer.

Signs and Symptoms of asbestosis can include:

Shortness of breath which is the primary symptom

A persistent and productive cough (a cough that expels mucus)

Chest tightness

Chest pain Loss of appetite

A dry, crackling sound in the lungs while inhaling.

If you suspect that you have been exposed to asbestos, speak with your physician immediately and discuss your level of exposure. Early detection of mesothelioma increases your chances immeasurably.

You can get more information about mesothelioma and find helpful information and resources here: http://rarereviews.com/mesothelioma-cancer




Latest Cancer News:



FDA panel votes against Xgeva for prostate cancer


A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients Breast cancer kills older women more often


NEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed with a certain type of breast cancer, those over 75 years old were 63 percent more likely to die of the cancer than women younger than 65. "I suspect it's ... Breast cancer charity chases Komen defectors


As a prominent breast cancer researcher and activist, Susan Love is no stranger to the Susan G. Komen Foundation. Love runs a breast cancer research foundation that bears her name, and she organized the Army of Women , more than 360,000 women to whom breast cancer researchers can blast out requests for subjects. But the Komen Foundation is so entrenched in the world of breast cancer fundraising ... A Better Way to Spend Breast Cancer Funds?


We must move breast cancer advocacy to the next level, beyond screening for cancers that are already there, even beyond the cure, to finding the cause, writes Dr. Susan Love. Cancer-hit cricketer Yuvraj vows to return stronger


India's cancer-stricken World Cup hero Yuvraj Singh has vowed to return "stronger than ever" to competitive cricket, saying he was responding well to treatment in the United States. Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Doxil/Caelyx (Ovarian Cancer) - Analysis and Forecasts to 2020 http://www.reportlinker.com/p0657184/Doxil/Caelyx-Ovarian-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=PathologyDoxil/Caelyx ... Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines


NEW YORK, Feb. 8, 2012  /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Triple Analysis: Lung Cancer, Angiogenesis and Cancer Vaccines http://www.reportlinker.com/p0284988/Triple-Analysis-Lung-Cancer-Angiogenesis-and-Cancer-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_MedicationThis ... Marian Regional Medical Center Receives CEO Cancer Gold Standard Accreditation


The CEO Roundtable on Cancer recently accredited Marian Regional Medical Center with the CEO Cancer Gold Standard? recognizing the hospital?s efforts to reduce the risk of cancer f Breast Cancer Drug May Weaken Bones, Study Finds


TUESDAY, Feb. 7 (HealthDay News) -- A drug used to prevent breast cancer in women at high risk for the disease appears to cause bone loss in some postmenopausal women, a new study finds. Marc Garnick Answers 6 Key Questions about Prostate Cancer


Marc Garnick Answers 6 Key Questions about Prostate Cancer Breast cancer kills older women more often - Fox News


News Image
Daily Mail

News Image
Breast cancer kills older women more often
Fox News
Print Email Share Comments Recommend Tweet Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease. Researchers found that among women who had been diagnosed ...
Breast cancer kills older women more often: studyReuters
Older women at breast cancer death riskTimes of India
Breast cancer screening 'no longer justified' and causes 7000 women a year to ...Daily Mail
ABC News -Tempo
all 100 news articles »
Insight: Komen charity under microscope for funding, science - Reuters


News Image
Los Angeles Times

News Image
Insight: Komen charity under microscope for funding, science
Reuters
By Sharon Begley and Janet Roberts | NEW YORK (Reuters) - The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it ...
Komen Board's Wisdom Lost on Scott WalkerHuffington Post (blog)
Komen foundation shouldn't give any money to Planned ParenthoodBaltimore Sun
Komen executive quits as questions persistLos Angeles Times

all 3,873 news articles »
FDA panel votes against Xgeva for prostate cancer - The Associated Press


News Image
USA TODAY

News Image
FDA panel votes against Xgeva for prostate cancer
The Associated Press
WASHINGTON (AP) ? A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients The Food and ...
Amgen Fails to Win Advisory Panel Backing for Expanded Use of Cancer DrugBloomberg
FDA questions Amgen drug for prostate cancerUSA TODAY
FDA Panel Votes Against Expanding Use Of Amgen Drug XgevaFox Business

all 87 news articles »
Pa. woman gets probation for fake cancer claims - USA TODAY



News Image
Pa. woman gets probation for fake cancer claims
USA TODAY
(AP) ? A Pennsylvania woman who submitted nearly $100000 worth of fake cancer treatment insurance claims for herself and her husband must repay the money while she serves nearly nine years on probation. The Observer-Reporter of Washington, ...

and more »
program takes cancer patients on Road to Recovery - Chicago Daily Herald



News Image
program takes cancer patients on Road to Recovery
Chicago Daily Herald
By Elisabeth Mistretta Kathy Miller of Arlington Heights sat inside Northwest Community Hospital near her home two years ago, feeling beaten down from radiation and chemotherapy treatments to treat her stage-four throat cancer.
Winter adds to ordeal of cancer patientsSTLtoday.com

all 2 news articles »
Slow-Growing Prostate Cancer Is Still 'Real Cancer' - Medscape



News Image
Slow-Growing Prostate Cancer Is Still 'Real Cancer'
Medscape
February 8, 2012 ? Low-grade low-volume prostate cancer often grows very slowly, and men presenting with this diagnosis might never experience morbidity or mortality as a result of the condition. However, hearing the emotionally charged term "cancer" ...
Ask Dr. K: Hot flashes in men are caused by low testosteroneGreenville Daily Reflector

all 3 news articles »
DNA sequencing helps identify cancer cells for immune system attack - Washington University in St. Louis News


News Image
Washington University in St. Louis News

News Image
DNA sequencing helps identify cancer cells for immune system attack
Washington University in St. Louis News
By Michael C. Purdy DNA sequences from tumor cells can be used to direct the immune system to attack cancer, according to scientists at Washington University School of Medicine in St. Louis. The research, in mice, appears online Feb. 8 in Nature.

and more »
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center - Sacramento Bee



News Image
Montblanc Announces Unprecedented Partnership With Texas Children's Cancer Center
Sacramento Bee
Montblanc and Texas Children's Cancer Center have joined together to support excellence in patient care, research and education to enhance the health and well being of our nation's children. To show personal commitment to this cause, Montblanc has ...
Texas Children's partners with Montblanc to raise fundsHouston Business Journal

all 8 news articles »
Breast cancer claims Purdue astronaut Janice Voss, 55 - Journal and Courier


News Image
RedOrbit

News Image
Breast cancer claims Purdue astronaut Janice Voss, 55
Journal and Courier
Astronaut Janice E. Voss, a Purdue University graduate and one of the few women launched into space, died Monday in Scottsdale, Ariz., after a battle with breast cancer. She was 55. Voss was part of five space shuttle missions, spending a total of 49 ...
Cancer Claims Five-Time Shuttle AstronautDiscovery News
Janice Voss, Shuttle Astronaut, Dies of Cancer at 55ThirdAge
NASA Astronaut Janice Voss Loses Battle Against Breast CancerRedOrbit
WIFR -French Tribune -Boston.com
all 190 news articles »
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review - Fox Business


News Image
Insciences Organisation

News Image
Roche Breast Cancer Drug Pertuzumab Gets FDA Priority Review
Fox Business
VX) experimental breast cancer drug pertuzumab, opening the way for a launch as early as 2012 for a product the Swiss company hopes can contain damage from lost sales when top seller Herceptin loses patent protection in a few years' time.
Roche breast cancer drug gets FDA priority reviewMarketWatch
FDA rewards Roche with priority review for blockbuster cancer drugFierceBiotech
FDA will speed up review of Roche cancer drugCBS News
PMLiVE -HemOncToday
all 53 news articles »

 



Home | Resource Links | Contact Us
Copyright © 2006 CancerAdvice.org